20.56

0.58% -0.12

Syndax Pharmaceuticals Inc (SNDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$20.68

Offen:

$20.46

24-Stunden-Volumen:

1.36M

Relative Volume:

0.77

Marktkapitalisierung:

$1.84B

Einnahmen:

$217.42M

Nettoeinkommen (Verlust:

$-243.25M

KGV:

-7.3555

EPS:

-2.7952

Netto-Cashflow:

$-278.35M

1W Leistung:

+5.22%

1M Leistung:

+7.76%

6M Leistung:

-4.90%

1J Leistung:

+26.99%

1-Tages-Spanne:

$20.46

$21.00

1-Wochen-Bereich:

$19.00

$21.00

52-Wochen-Spanne:

$12.99

$25.59

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Firmenname

Syndax Pharmaceuticals Inc

Sektor

Healthcare (1074)

Branche

Biotechnology (600)

Telefon

781-419-1400

Adresse

730 THIRD AVENUE, NEW YORK, MA

Mitarbeiter

298

Twitter

@syndax

Nächster Verdiensttermin

2026-08-03

Neueste SEC-Einreichungen

SNDX's Discussions on Twitter

Compare SNDX vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SNDX Syndax Pharmaceuticals Inc	20.56	1.76B	217.42M	-243.25M	-278.35M	-2.7952
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-16	Fortgesetzt	H.C. Wainwright	Buy
2025-09-10	Fortgesetzt	Stifel	Buy
2025-09-04	Fortgesetzt	Guggenheim	Buy
2025-08-05	Bestätigt	BTIG Research	Buy
2025-07-10	Eingeleitet	Goldman	Buy
2024-10-24	Eingeleitet	UBS	Buy
2024-06-28	Eingeleitet	Jefferies	Buy
2024-01-31	Herabstufung	Scotiabank	Sector Outperform → Sector Perform
2023-12-22	Eingeleitet	Mizuho	Buy
2023-10-25	Eingeleitet	BofA Securities	Buy
2023-10-11	Eingeleitet	Goldman	Buy
2023-07-27	Eingeleitet	Scotiabank	Sector Outperform
2023-07-11	Eingeleitet	Guggenheim	Buy
2023-04-17	Fortgesetzt	BTIG Research	Buy
2023-01-31	Eingeleitet	Stifel	Buy
2023-01-03	Eingeleitet	JP Morgan	Overweight
2022-07-28	Fortgesetzt	B. Riley Securities	Buy
2022-04-11	Eingeleitet	H.C. Wainwright	Buy
2022-02-15	Eingeleitet	Goldman	Buy
2021-06-04	Fortgesetzt	Robert W. Baird	Outperform
2021-05-25	Eingeleitet	Citigroup	Buy
2021-02-18	Eingeleitet	B. Riley Securities	Buy
2020-12-03	Eingeleitet	Stifel	Buy
2020-05-22	Hochstufung	Citigroup	Neutral → Buy
2020-05-22	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-05-18	Herabstufung	Citigroup	Buy → Neutral
2020-05-11	Bestätigt	H.C. Wainwright	Buy
2020-03-04	Eingeleitet	Barclays	Overweight
2020-01-13	Bestätigt	H.C. Wainwright	Buy
2019-03-08	Bestätigt	H.C. Wainwright	Buy
2019-01-04	Eingeleitet	Robert W. Baird	Outperform
2018-01-05	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-03-16	Eingeleitet	FBR & Co.	Outperform
2017-03-02	Eingeleitet	Instinet	Buy
2016-10-07	Eingeleitet	Guggenheim	Buy
2016-03-28	Eingeleitet	Citigroup	Buy
2016-03-28	Eingeleitet	JMP Securities	Mkt Outperform
2016-03-28	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Syndax Pharmaceuticals Inc Aktie (SNDX) Neueste Nachrichten

Aug 21, 2026

SNDX Maintained by UBS -- Price Target Lowered to $33 - GuruFocus

Aug 21, 2026

UBS lowers Syndax Pharmaceuticals price target on revenue outlook By Investing.com - Investing.com Canada

Aug 21, 2026

Aug 20, 2026

Syndax (SNDX) Q2 2026 Earnings Call Transcript - AOL.com

Aug 20, 2026

Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates - Eastern Progress

Aug 20, 2026

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Aug 20, 2026

Wall Street Analysts Think Syndax (SNDX) Could Surge 70.38%: Read This Before Placing a Bet - Eastern Progress

Aug 20, 2026

Syndax (SNDX) Quarterly Results: Profit Per Share Falls Below Its Benchmark in the Reported Period; Trading Move - vinanet.vn

Aug 20, 2026

Aug 19, 2026

Exploring 3 High Growth Tech Stocks In The US Market - Sahm

Aug 19, 2026

Aug 18, 2026

Syndax Pharmaceuticals (SNDX) Edges Up 0.46% to $19.85 as Range-Bound Trading PersistsHigh Low Breadth - vinanet.vn

Aug 18, 2026

Aug 17, 2026

GSA Capital Partners LLP Purchases New Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Aug 17, 2026

Aug 14, 2026

Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $40 - Moomoo

Aug 14, 2026

SNDX Stock Price, Quote & Chart - ChartMill

Aug 14, 2026

Aug 12, 2026

The Technical Signals Behind (SNDX) That Institutions Follow - Stock Traders Daily

Aug 12, 2026

Syndax (SNDX) Sales Nearly Doubled, So Why Did The Stock Fall? - Yahoo Finance

Aug 12, 2026

Aug 11, 2026

SNDX Maintained by JP Morgan -- Price Target Lowered to $40.00 - GuruFocus

Aug 11, 2026

Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $40.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Aug 11, 2026

J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $40 - Moomoo

Aug 11, 2026

Syndax Pharmaceuticals (SNDX) Short Interest & Short Float | Updated Aug 2026 - MarketBeat

Aug 11, 2026

Aug 09, 2026

Hennion & Walsh Asset Management Inc. Increases Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Aug 09, 2026

Aug 08, 2026

Bank of America Corp DE Decreases Position in Syndax Pharmaceuticals, Inc. $SNDX - marketbeat.com

Aug 08, 2026

Aug 07, 2026

Net margin % of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026

Long term debt to total assets ratio of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026

Total common shares outstanding of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026

Price to sales forward of Syndax Pharmaceuticals Inc – HAM:1T3 - TradingView

Aug 07, 2026

State Street Corporation (SNDX) discloses 5.66M-share, 6.4% holding in Syndax - Stock Titan

Aug 07, 2026

How Surging Revuforj and Niktimvo Sales and Narrowing Losses Could Shape Syndax Pharmaceuticals (SNDX) Investors - Yahoo Finance

Aug 07, 2026

Syndax Pharmaceuticals Inc (1T3) Q3 2024 Earnings ReportResults, Call & Slides - tipranks.com

Aug 07, 2026

Earnings Update: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Just Reported And Analysts Are Trimming Their Forecasts - simplywall.st

Aug 07, 2026

HC Wainwright Brokers Decrease Earnings Estimates for SNDX - MarketBeat

Aug 07, 2026

Aug 06, 2026

Syndax Pharmaceuticals Inc (1T3) Q1 2024 Earnings ReportResults, Call & Slides - tipranks.com

Aug 06, 2026

Surging Revenue And Narrower Losses Might Change The Case For Investing In Syndax Pharmaceuticals (SNDX) - webull.com

Aug 06, 2026

What is HC Wainwright's Estimate for SNDX FY2029 Earnings? - MarketBeat

Aug 06, 2026

BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $26 - Moomoo

Aug 06, 2026

Aug 05, 2026

A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $26 to $57 - Moomoo

Aug 05, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Aug 05, 2026

Five New Syndax Employees Receive Stock Options With 4-Year Vesting - Stock Titan

Aug 05, 2026

Syndax Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SNDX) 2026-08-05 - Seeking Alpha

Aug 05, 2026

Syndax Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $38.27, Implies 101% Upside - TradingView

Aug 05, 2026

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down on Disappointing Earnings - MarketBeat

Aug 05, 2026

SNDX Maintains Rating by HC Wainwright & Co. -- Price Target Low - GuruFocus

Aug 05, 2026

HC Wainwright Has Lowered Expectations for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price - marketbeat.com

Aug 05, 2026

Sei Investments Co. Grows Stake in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Aug 05, 2026